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HYDROGEN SULFIDE (H 2 S) has long been known as a noxious and toxic gas. However, recent studies showing that vertebrates produce endogenous H 2 S and that it fulfills all the criteria of a signaling molecule, have led to H 2 S being called the third "gasotransmitter," thereby joining NO and CO (24) in this role. H 2 S is both a neuromodulator and neuroprotectant (14) , and H 2 S-mediated effects as well as endogenous H 2 S synthesis have been described throughout the entire body, from brain to gut (12) . Within the vasculature, H 2 S is synthesized by the enzyme, cystathionine ␥-lyase (CSE), and by the tandem enzymes, cysteine aminotransferase (CAT) and 3-mercaptopyruvate sulfur transferase (3-MST), which catalyze the sequential transfer of sulfur from cysteine to ␣-ketoglutarate to form 3-mercaptopyruvate and then H 2 S (Fig. 1) . CSE is localized in the endothelium and smooth muscle while CAT and 3-MST are found in mitochondria and cytoplasm (11) . Cystathionine ␤-synthase (CBS), an enzyme involved in H 2 S synthesis in other organs, has not yet been found in vascular smooth muscle but has been identified in the endothelium (13, 20) .
To date, most studies on the vascular effects of H 2 S have focused primarily on systemic vessels, where it has been shown to dilate preconstricted arteries and veins (4, 10, (31) (32) (33) . This effect appears to be mediated in part through activation of ATP-sensitive K ϩ (K ATP ) channels, and to a lesser extent to activation of Ca 2ϩ -dependent K ϩ (K Ca ) channels, and possibly H 2 S-mediated endothelial NO release (25, (32) (33) (34) . In whole animals, intraperitoneal injection of a CSE inhibitor increased mean arterial blood pressure in rats (31) and CSE-deficient mice developed age-dependent hypertension (30) .
Within the pulmonary vascular bed, H 2 S is known primarily for its toxic effects, which are often associated with pulmonary edema (22) , suggesting that either capillary permeability or pulmonary blood pressure is increased. However, recent studies in isolated pulmonary arteries from various species (9, 17) showed that the effects of H 2 S on the pulmonary vasculature are strikingly similar to those produced by acute hypoxia. Both hypoxia and H 2 S produce almost identical contractile patterns that are accompanied by membrane depolarization and myosin light chain phosphorylation (9, 17) . Inhibitors of H 2 S biosynthesis inhibit the hypoxic response while sulfur donors including cysteine, cysteine plus ␣-ketoglutarate, and glutathione augment it. H 2 S production by a variety of tissues is inversely coupled to O 2 availability at physiologically relevant PO 2 (19) . A similar activation of O 2 -sensing glomus cells in the carotid body and neural epithelial cells in the fish gill has led to the hypothesis that H 2 S is the critical couple between PO 2 and tissue responses to hypoxia (18, 19) . The involvement of H 2 S in HPV has not, however, been studied in the intact lung. In the present study, we used an intact, isolated, perfused rat lung preparation to examine whether adding compounds essential to H 2 S synthesis or compounds that inhibited its synthesis would result in a corresponding increase or decrease in the magnitude of HPV.
MATERIALS AND METHODS
The Institutional Animal Care and Use Committee of the Zablocki Veterans Administration Medical Center approved the animal handling protocol for this study. Male Sprague-Dawley rats (366 Ϯ 12 g) were anesthetized with pentobarbital sodium (40 -50 mg/kg ip). The neck was opened and the trachea clamped to keep the lung inflated. The chest was immediately opened and the rat was heparinized (700 units/kg) by direct cardiac puncture into the right ventricle. The pulmonary artery was cannulated and the heart completely cut away to expose the pulmonary vein followed by cannulation of the trachea. The lung was then suspended in the perfusion apparatus via the arterial and tracheal cannulas and perfused at 10 ml/min with a physiological salt solution containing (in mM) 4.7 KCl, 2.5 CaCl 2, 0.57 MgSO4, 2.5 KH2PO4, 118 NaCl, 25 NaHCO3, and 5.5 glucose (pH 7.4 at 37°C). The perfusate also contained 4.5% Ficoll (sucrose polymer, 70,000 g/mol) to maintain constant oncotic pressure and 3 M meclofenamate plus 0.1 mM N -nitro-L-arginine, to prevent the release of vasodilator prostaglandins and NO, respectively. The lung was respirated at 40 breaths/min with a normoxic gas mixture (15% O 2, 6% CO2, balance N2) and initial end inspiration and end expiration pressures of 7.5 and 2.5 cmH2O, respectively. Initially, the venous effluent was diverted into a waste container until residual blood was washed out of the lung after which perfusate (total volume 32 ml) was continuously recirculated through the lung for a 15 min equilibration period.
Experimental protocols. The protocol used and the increase in pulmonary arterial pressure in the isolated perfused rat lung induced by acute hypoxia were similar to that described by Weigand et al. (27) . Briefly, under normoxic conditions a bolus (0.2 ml) dose of 0.05 g of ANG II was injected into the isolated lung via the pulmonary artery cannula and the spike in arterial pressure allowed to return to baseline (ϳ3 min). The ventilation gas mixture was then rapidly switched to the hypoxic mixture (6% CO 2, balance N2) and the transient increase in pulmonary artery pressure recorded with time. Just after the maximum hypoxic arterial pressure was achieved the ventilation gas was switched back to normoxia. Once the arterial pressure returned to a stable baseline (ϳ3 min) the sequence of ANG II followed by hypoxia was repeated for a total of five hypoxic episodes designated H1 through H5. The magnitude of the pulmonary artery pressure (cmH 2O) after the stabilization of the ANG II contraction and before hypoxia, subtracted from the hypoxia-induced peak arterial pressure was used as the measure of HPV for each episode.
Cysteine and reduced (GSH) or oxidized (GSSG) glutathione, diethylmaleate (DEM) and ␣-ketoglutarate (␣KG), aspartate, aminooxyaceticacid (AOAA), and propargylglycine (PPG), were obtained from Sigma-Aldrich (St. Louis, MO). All other chemicals were of reagent grade. They were dissolved in saline except for DEM, which is a liquid. All were added directly to the lung perfusate either during the 15 min equilibration period or between the fourth and fifth hypoxic episodes. The final lung perfusate concentrations of cysteine, GSSG, GSH, and ␣KG were 1 mM; aspartate, AOAA and PPG were 10 mM; and DEM from 0.25 to 5 mM.
Polarographic electrode studies. In an attempt to obtain more direct evidence of H 2S production during hypoxia, fresh rat lung homogenate and rat small pulmonary arteries were placed in a small (1.0 ml vol) closed, temperature-controlled cell containing physiological salt solution and O 2 and H2S polarographic electrodes to monitor the change in O2 and H2S in the system. The H2S polarographic electrode was calibrated at 37°with Na2S standards immediately prior to and again after each experiment. The standards were made up in N2-sparged buffer and used immediately for calibration. Both the lung homogenate and the pulmonary arteries were initially equilibrated with 100% N2 to lower the O2 concentration in the presence of cysteine and ␣-ketoglutaric acid (substrate for the 3-MST enzyme). After 20 min, 8 l of air was introduced into the system and the change in H 2S monitored.
Western blots. Western blots were performed on homogenized lungs using methodologies previously described (15, 20) . Antibodies for cystathione ␤-synthase (CBS; Santa Cruz Biotechnology, Santa Cruz, CA), cystathionine ␥-lyase (CSE; Novus Biologicals, Littleton, CO), and 3-mercaptopyruvate sulfur transferase (3-MST; SigmaAldrich, St. Louis, MO) were used.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical analyses were performed using Student's t-test or ANOVA. Differences were considered significant at P Ͻ 0. 05.
RESULTS
The presence in the lung of enzymes known to produce H 2 S was determined from the Western blot shown in Fig. 2 . Both CSE and 3-MST were clearly indentified in the rat lung homogenate. The absence of the CBS enzyme is consistent with the work of others showing that this enzyme is found primarily in brain tissue (12) . Figure 3A shows a typical recording of pulmonary arterial pressure during five episodes of exposure to ANG II and hypoxia in a control rat lung. The magnitude of the transient rise in pulmonary artery pressure during hypoxia increased with subsequent hypoxic episodes. The gradual increase in baseline arterial pressure during an experiment is due to accumulation of circulating ANG II in the perfusate, the long duration of perfusion (75 min), and the development of some edema caused by the transient high pulmonary artery pressures in the latter episodes of acute HPV. The histogram in Fig. 3B shows the increase in the mean hypoxia-induced arterial pressure for hypoxic episodes H1 to H5 in control lungs (n ϭ 19). The large n results from the fact that the effect of hypoxia in control lungs was determined throughout the course of the study. The arterial pressure increase in the control lungs was significantly greater (P Ͻ 0.05) for each hypoxic episode, reaching a maximum of 14.4 Ϯ 1.2 cmH 2 O at H5.
Initially, we focused on how altering H 2 S production by the CSE and 3-MST enzyme pathways in the isolated perfused lung affected the arterial pressure in response to hypoxia. For the first of these experiments, the sulfur donors, cysteine, GSSG, or GSH, were added to the perfusate and allowed to recirculate through the lung during the 15 min equilibration period. This was followed by the five ANG II/hypoxia episodes and the increases in arterial pressure measured for each one. Cysteine is the predominate precursor of H 2 S production by CSE and 3-MST while glutathione serves as an in situ source of cysteine. The arterial pressure increase for each hypoxic episode (H1 through H5) in control lungs was compared to its corresponding hypoxic episode in lungs perfused with cysteine, GSSG, or GSH, and the results are shown in Fig. 4A . The presence of the three H 2 S precursors significantly (P Ͻ 0.05) increased arterial pressure by 75-100% compared with control for all hypoxic episodes, with one exception. The arterial pressure during H5 with added cysteine while ϳ75% higher was not statistically different from the H5 control. All other data points demonstrated a significant correlation between these added precursors of H 2 S synthesis and the magnitude of the hypoxic response. The ANG II responses in the presence of cysteine, GSSG, and GSH were not significantly different from those measured in control lungs ( Fig. 4B ; P Ͼ 0.05 for all). Fig. 4 . A: histogram of changes in pulmonary artery pressure during hypoxic episodes 1 through 5 of control lungs (Con; n ϭ 19) and lungs treated with cysteine (Cys; n ϭ 7), oxidized (GSSG; n ϭ 6) and reduced glutathione (GSH; n ϭ 4); all at 1 mM; *Significantly different from control. B: histogram of changes in pulmonary artery pressure during ANG II episodes 1 through 5. A more specific approach for altering pulmonary H 2 S production was to add ␣-ketoglutarate to the lung perfusate to enhance the 3-MST enzyme pathway. Cysteine aminotransferase (CAT) converts ␣-ketoglutarate and cysteine to 3-mercaptopyruvate, which is converted to H 2 S by 3-MST (Fig. 1) . Figure 5A shows a recording of the pulmonary artery pressure for episodes H1 through H5. Adding ␣-ketoglutarate after H4 resulted in a large increase in arterial pressure during H5. If ␣-ketoglutarate was added at the start of the perfusion the resulting high arterial pressures for all hypoxic episodes resulted in more rapid lung edema, thereby limiting the number of hypoxic episodes. Therefore, the ␣-ketoglutarate-induced pressure change is expressed as the percent increase of episode H5 over H4. Figure 5B shows that adding ␣-ketoglutarate resulted in a 130% increase in arterial pressure, further supporting a role of H 2 S in HPV.
The effect of using aspartic acid to inhibit the 3-MST pathway for H 2 S synthesis was also investigated. Aspartic acid competitively inhibits CAT, thereby blocking conversion of cysteine to 3-mercaptopyruvate and thus H 2 S production by 3-MST. Aspartic acid was added to the lung perfusate and recirculated through the lung during the 15 min equilibration period. Immediately after episode H4, ␣-ketoglutarate was added to the perfusate as before and the change in arterial pressure again expressed as the percent change of H5 over H4. As shown in Fig. 5B in the presence of both ␣-ketoglutarate and aspartate the percent change in arterial pressure from H4 to H5 was greatly reduced and was similar to control, further implicating 3-MST-generated H 2 S in HPV. Neither aspartate nor ␣-ketoglutarate had any effect on the magnitude of the ANG II responses ( Fig. 5C ; P Ͼ 0.05 for both).
The effect of inhibition of the CSE pathway on arterial pressure during hypoxia was also examined by adding the CSE inhibitor, PPG, to the lung perfusate between episodes H3 and H4. The change in arterial pressure for episodes H4 and H5 is expressed as the percent change in pressure at H3 for both control and PPG-treated lungs (Fig. 6A) . In control lungs the arterial pressures for episodes H4 and H5 were, respectively, 64 Ϯ 11 and 121 Ϯ 27% greater than episode H3 (P Ͻ 0.05 for both). In contrast, adding PPG to the lung perfusate resulted in a 50 Ϯ 14% and a 60 Ϯ 10% decrease (P Ͻ 0.05 for both) in arterial pressures between H4 and H5 compared to its respective H3. The ANG II responses were similar before and after adding PPG to the perfusate ( Fig. 6B ; P Ͼ 0.05). Finally, lungs treated with the CBS inhibitor, AOAA, did not show any diminution of the hypoxic response (data not shown), consistent with the absence of the CBS enzyme in the Western blot (Fig. 2) .
Another approach to decrease in situ H 2 S production in the isolated lung involved recirculation of various concentrations of DEM (0.25 to 5.0 mM) through the lung during the 15 min equilibration. DEM is one of many ␣␤-unsaturated compounds that form conjugates with sulfhydryls such as cysteine and glutathione catalyzed by glutathione S-transferases, and it has been widely used to deplete glutathione (1, 3, 7) . Figure 7A shows a plot of perfusate DEM concentration versus mean peak pulmonary artery pressure for episode H5. The three horizontal lines denote the mean Ϯ SE arterial pressure at episode H5 for the control lungs. At the highest DEM concentration (5 mM) the hypoxia-induced arterial pressure increase was only 1.3 Ϯ 0.03 cmH 2 O compared with 14.2 Ϯ 1.2 Fig. 7B ; P Ͻ 0.05), these decreases were significantly less than those noted for the hypoxic responses, which were 79.0 Ϯ 0.04 and 91.0 Ϯ 0.02%, respectively (P Ͻ 0.05).
At decreasing DEM concentrations the peak arterial pressure during hypoxia increased and was similar to control levels at 1.0 mM DEM, further supporting a relationship between endogenous H 2 S precursors and hypoxic pulmonary vasoconstriction. However, at DEM concentrations Ͻ1.0 mM, the pulmonary arterial pressure at H5 began to increase further and was significantly greater than control at both 0.5 and 0.25 mM (P Ͻ 0.05). Concentrations of DEM less than 4 mM had no effect on ANG II responses ( Fig. 7B ; P Ͼ 0.05). Several reports have shown that at low concentrations (0.05 to 0.5 mM) DEM increases the cellular concentrations of glutathione, cysteine, and glutamate (6, 21) . The increase in glutathione at low DEM has been attributed to increased cystine and glutamate transport activity into cells (2) . Increased glutathione concentrations at low DEM concentrations have been reported in bovine lung artery endothelial cells (6, 21) , bovine lung artery smooth muscles cells, rat lung fibroblasts, and rat lung epithelial-like cells (21) . Figure 8A shows lung homogenate concentrations of H 2 S and O 2 with time starting at a low O 2 concentration. After ␣-ketoglutaric acid was added the H 2 S concentration increased markedly. Injection of 8 l of air into the system increased the 
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O 2 concentration and simultaneously resulted in a sharp decrease in H 2 S. The H 2 S concentration increased again once the O 2 was depleted. This experiment demonstrates H 2 S release at a low O 2 concentration and is consistent with mitochondrial MPST enzyme-mediated H 2 S production in this lung tissue homogenate system. Figure 8B shows the result of the experiment using this method with small pulmonary arteries freshly dissected from rat lungs. Similar to the lung homogenate study shown in Fig.  8A , H 2 S produced by the small pulmonary arteries increased during hypoxic conditions in the presence of cysteine and ␣-ketoglutaric acid. Upon injecting air into the system, the H 2 S concentration decreased until the O 2 was depleted, whereupon the H 2 S level again rose. This experiment specifically demonstrates the release of H 2 S from isolated pulmonary arterial tissue during hypoxia.
DISCUSSION
The present work used the isolated perfused rat lung to provide additional evidence that H 2 S production during hypoxia is involved in HPV. The intact organ model was useful for this study since the lung exhibits a transient increase in pulmonary arterial pressure in response to hypoxia and the increasing peak arterial pressures with successive hypoxic episodes allows a given lung to be used both as its own control, and/or be compared with a separate control group. Furthermore, compounds known to inhibit or stimulate H 2 S could be added directly into the recirculating perfusate at any time point during the experiment.
The results of this approach provided consistent support for a role for H 2 S in HPV. First, two major enzymes involved in H 2 S synthesis, CSE and 3-MST, were found in the lung tissue, but another enzyme, CBS, was not (Fig. 2) . The absence of the CBS enzyme was further confirmed when addition of the CBS inhibitor AOAA to the perfusate had no effect on any of the hypoxia-induced increases in arterial pressure. These results agree with those of others who did not detect CBS in rat pulmonary arteries (33) and that AOAA did not block H 2 S production in rat vessel homogenates (10) . However, we should note that our group has detected the CBS enzyme in bovine pulmonary artery endothelial cells (20) and that AOAA partially inhibited H 2 S production in bovine pulmonary arteries and veins (17) . Also, Wang et al. (23) showed that mouse pulmonary vascular smooth muscle and endothelial cells expressed CBS. Thus the enzymes involved in pulmonary vascular H 2 S synthesis may be species specific.
In the present study, compounds that stimulated or inhibited the CSE or 3-MST-catalyzed synthesis of H 2 S significantly affected pulmonary arterial pressure during acute hypoxia (Figs. 3-7) . Cysteine, GSH, or GSSH added to the perfusate to increase the cysteine concentration of the vascular smooth muscle cells resulted in a near doubling of arterial pressure during acute hypoxia. These three compounds ultimately result in an increased synthesis of GSH in lung tissue, thereby leading to a more reduced redox state of the lung, which would favor both H 2 S production and increasing its stability.
It has been postulated that HPV is mediated by an increased production of reactive oxygen species (ROS) and that "an antioxidant should suppress HPV without mimicking hypoxia" (26) . However, Weir et al. (26, 28) have proposed "that HPV is signaled by a decrease in ROS or by more reduced redox couples." This latter theory is consistent with our finding of a large increase in HPV in the rat lung when cysteine or glutathione was added to the perfusate. Further support for a reduced redox status contributing to HPV comes from the experiments in which we depleted sulfhydryls (cysteine or GSH) by adding DEM to the lung perfusate. In these studies the hypoxia-induced increase in arterial pressure was significantly reduced and approached zero increase at the highest DEM concentration (Fig. 7) . At the highest doses of DEM (4 and 5 mM) the ANG II response was also reduced, which might suggest that DEM was not totally specific for inhibition of just the hypoxic response; however, this result is not surprising since the general mechanism of action of DEM is via reaction with free sulfhydryls that could be present in factors involved in the ANG II response and be manifested at high concentrations of DEM. More importantly, however, the unusual finding that at very low DEM perfusate concentrations HPV was greater than in control lungs (with no effect on ANG II responses) is also consistent with the view that a reduced redox status contributes to HPV since very low concentrations of DEM result in elevated cellular GSH due to the increased uptake of glutamate and cystine (2, 6) . This would increase lung cysteine concentrations, favoring higher H 2 S production and/or a more reduced redox status in lung tissue.
As noted in the introduction, CAT catalyzes the formation of 3-mercaptopyruvate from ␣-ketoglutaric acid and cysteine, which then becomes the substrate for 3-MST catalyzed production of H 2 S. The greater than fourfold increase in HPV in the presence of ␣-ketoglutarate in the perfusate (Fig. 5) provides more specific evidence for a role of H 2 S in HPV. This is further supported by the inhibition of HPV (Fig. 5) when aspartic acid, a competitive inhibitor of CAT, was added to the perfusate after ␣-ketoglutarate. The fact that the magnitude of HPV in the presence of both ␣-ketoglutarate and aspartate was similar to that of control might suggest that in the isolated lung preparation the contribution of the CAT-3-MST enzyme pathway in HPV is limited by the endogenous ␣-ketoglutarate concentration. Whether this is due to washout of ␣-ketoglutarate during the 15 min washout perfusion at the start of the experiment or that ␣-ketoglutarate levels are merely low in the lung tissue cannot be determined from these experiments. Finally, adding PPG to the perfusate to inhibit the CSEmediated synthesis of H 2 S produced the expected decrease in HPV (Fig. 6 ) and is consistent with our previous finding that another CSE inhibitor, ␤-cyanoalanine, inhibited the hypoxic response in rat isolated pulmonary arteries (17) . It is difficult to envision that the observed differential effects of these three similar low molecular weight organic acids (aspartate, ␣-ketoglutarate, and PPG) on HPV could occur via mechanisms other than their known interactions with the enzymes involved with H 2 S production.
The results of the experiments described above do not individually constitute proof of the involvement of H 2 S in HPV. However, taken together the constancy of each result does provide reasonable circumstantial evidence that the rate of H 2 S synthesis plays a role in the magnitude of acute HPV in the isolated perfused rat lung. Our findings are also substantiated by a recent study by Derwall et al. (8) who found that administration of H 2 S via ventilation of an extracorporeal membrane lung in sheep caused significant dose-dependent pulmonary vasoconstriction. In contrast, it should be noted that a study done in chronically hypoxic rats found that one of the enzymes responsible for H 2 S synthesis was reduced in systemic vessels (5). Plasma [H 2 S] was also lower in these animals, which led the authors to suggest that overall H 2 S production was reduced and that a hypoxia-induced loss in tonic H 2 S dilation contributed to chronic hypoxic pulmonary vasoconstriction. While at first glance these results would appear to argue against a role for H 2 S in HPV, all information was collected from systemic vessels; no pulmonary vessels were studied. Furthermore, recent studies have questioned the validity of plasma H 2 S measurements (29) .
Further proof of the dependence of HPV on H 2 S synthesis ideally would involve correlation of the magnitude of the HPV response during hypoxia with the amount of H 2 S released from the isolated lung. This is not a simple task since the amount of H 2 S produced during hypoxia is very small and it is rapidly released from the lung tissue. It then becomes so highly diluted in both the perfusate fluid and the expired gas under the existing perfusate flow and respiration rates used in the intact lung (10 ml/min and 40 breaths/min) that it is not feasible to measure it with any currently available techniques. It has, however, been shown that isolated vessels and smooth muscle cells placed in a small volume closed system and perfused at a flow rate 1 ml/min or lower produced H 2 S in response to hypoxia as measured with a specially designed polarographic electrode (29) . This technique would not be feasible in the isolated perfused rat lung preparation used in our study.
Other studies have used sodium hydrosulfide (NaHS) in order to produce H 2 S and study its effects. This approach is problematic since there can be significant loss of H 2 S to the atmosphere and thus result in an inability to determine the exact concentration of H 2 S present in the experimental preparation. Indeed, when we tried this approach in the isolated perfused lung there was out-gassing from the 37°C perfusate and by respiration, which resulted in a constantly decreasing H 2 S concentration. A number of H 2 S-releasing compounds are now available (16) , and these might prove useful in future studies, although perhaps not in an acute hypoxic situation as described in this study. While definitive evidence of the role of H 2 S and elucidation of the mechanisms involved in its action in an intact organ such as the lung await the development of new, more sensitive and directed techniques, the results of this study coupled with those from Derwall et al. (8) strongly suggest that pharmacological manipulations aimed at altering H 2 S biosynthesis could serve as an effective mean to modulate HPV in the intact lung.
